Groundbreaking First-in-Human Study Demonstrates Potential to Treat Type 1 Diabetes by Transplanting Insulin-Secreting Cells Without ...
In a 14-month follow-up, Sana Biotechnology has found that its investigational allogeneic cell therapy continued to produce insulin in one patient with Type 1 diabetes, with no safety concerns ...
Some supplements promise health benefits, but experts warn that certain products may interfere with medications or affect blood sugar control in people living with diabetes.
Single cell transcriptomic profiling of appendiceal adenocarcinoma to identify rare tumor cells and a myeloid-enriched tumor microenvironment (TME). This is an ASCO Meeting Abstract from the 2024 ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results